AS
Abhaybhai Subodhbhai Maheta
About Abhaybhai Subodhbhai Maheta
Data last updated:
Abhaybhai Subodhbhai Maheta is a Director at Flax Laboratories Private Limited (since 2025) and Director at Dwirayu Pharma Private Limited (since 2023). The companies operate in Pharma, Paper and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹56.76 Cr; the largest is Flax Laboratories Private Limited at ₹52.86 Cr (FY 2025). Earlier, Abhaybhai Subodhbhai Maheta was a Director at Linum Healthcare Private Limited (2018–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Apr 2025 | 2021 | ₹52.86 Cr (FY 2025) | Active | |
| Director | 06 Apr 2023 | 2023 | ₹3.90 Cr (FY 2026) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 08 May 2018 | 2018 | ₹8.77 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Abhaybhai Subodhbhai Maheta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bharatbhai Govindbhai Suthar | 07766631 | Flax Laboratories Private Limited | Director |
| Hetal Maheta Abhay | 07765857 | Flax Laboratories Private Limited | Director |
| Kirti Dwarkadas Gaudani | 07766572 | Flax Laboratories Private Limited | Director |
| Rajni Dwarkadas Gaudani | 07765846 | Flax Laboratories Private Limited | Director |
| Rekhaben Bharatbhai Suthar | 07765821 | Flax Laboratories Private Limited | Director |
| Mital Ankur Kaneria | 10103905 | Dwirayu Pharma Private Limited | Director |
| Nileshbhai Mansukhlal Thumar | 10446737 | Dwirayu Pharma Private Limited | Additional Director |
| Rekha Nilesh Thumar | 10103904 | Dwirayu Pharma Private Limited | Director |
| Shilpaben Pankajbhai Butani | 10103903 | Dwirayu Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abhaybhai Subodhbhai Maheta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abhaybhai Subodhbhai Maheta
Abhaybhai Subodhbhai Maheta currently holds 2 directorships: Flax Laboratories Private Limited (Director, since 01 Apr 2025, revenue ₹52.86 Cr (FY 2025)); Dwirayu Pharma Private Limited (Director, since 06 Apr 2023, revenue ₹3.90 Cr (FY 2026)).
Abhaybhai Subodhbhai Maheta was first appointed on 08 May 2018 as Director at Linum Healthcare Private Limited. The most recent appointment on record is 01 Apr 2025 at Flax Laboratories Private Limited.
The 2 current companies of Abhaybhai Subodhbhai Maheta that report revenue have a combined latest revenue of ₹56.76 Cr: Flax Laboratories Private Limited ₹52.86 Cr (FY 2025); Dwirayu Pharma Private Limited ₹3.90 Cr (FY 2026).
Abhaybhai Subodhbhai Maheta held 1 earlier board appointment: Linum Healthcare Private Limited (Director, 08 May 2018 to 15 Feb 2023).
The current boards of Abhaybhai Subodhbhai Maheta's companies include Bharatbhai Govindbhai Suthar (Flax Laboratories Private Limited), Hetal Maheta Abhay (Flax Laboratories Private Limited), Kirti Dwarkadas Gaudani (Flax Laboratories Private Limited), Rajni Dwarkadas Gaudani (Flax Laboratories Private Limited), Rekhaben Bharatbhai Suthar (Flax Laboratories Private Limited), Mital Ankur Kaneria (Dwirayu Pharma Private Limited), among others.